Literature DB >> 19867558

EXPERIMENTAL BRONCHOPNEUMONIA BY INTRABRONCHIAL INSUFFLATION.

M Wollstein1, S J Meltzer.   

Abstract

When intrabronchial insufflation of pure cultures of the streptococcus or of the influenza bacillus is properly carried out, it produces without fail a pneumonic lesion. This lesion is similar in its nature to the one known in human pathology as bronchopneumonia, and differs materially from the pneumonic lesion produced experimentally by the intrabronchial insufflation of pure cultures of the pneumococcus. Considering the fact that none of the dogs used in the experiments with the pneumococcus and none of those used in the present investigation were selected or prepared in any way, the conclusion seems to be unavoidable that the proper invasion of the microörganism is the determining factor in the development of pneumonia, the condition of the animal being only a minor element in this regard. Furthermore, since different organisms introduced in the same way and under conditions which are apparently the same produced distinctly different pneumonic lesions in animals of the same species, the further conclusion presents itself that the different types of pneumonia are produced by specifically different bacteria. However, further investigation may show that the differences in the nature of the lesion are due rather to the degree of virulence of the causative microörganism than to differences in the species; that is, that different lesions may possibly be produced by organisms of the same species, provided they possess different degrees of virulence. Further experimentation may also show that the condition of the animal and of the affected organ which, in the onset and development of the pneumonic disease, is, perhaps, unimportant, may be the leading factor in determining the course and outcome of the disease.

Entities:  

Year:  1912        PMID: 19867558      PMCID: PMC2125244          DOI: 10.1084/jem.16.2.126

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  1 in total

1.  EXPERIMENTAL PNEUMONIA BY INTRABRONCHIAL INSUFFLATION.

Authors:  R V Lamar; S J Meltzer
Journal:  J Exp Med       Date:  1912-02-01       Impact factor: 14.307

  1 in total
  8 in total

1.  STUDIES ON EXPERIMENTAL PNEUMONIA : II. PATHOLOGY AND PATHOGENESIS OF PNEUMOCOCCUS LOBAR PNEUMONIA IN MONKEYS.

Authors:  F G Blake; R L Cecil
Journal:  J Exp Med       Date:  1920-03-31       Impact factor: 14.307

Review 2.  Persistent and Recurrent Bacterial Bronchitis-A Paradigm Shift in Our Understanding of Chronic Respiratory Disease.

Authors:  Alya Ishak; Mark L Everard
Journal:  Front Pediatr       Date:  2017-02-15       Impact factor: 3.418

3.  STUDIES ON EXPERIMENTAL PNEUMONIA : X. PATHOLOGY OF EXPERIMENTAL INFLUENZA AND OF BACILLUS INFLUENZAE PNEUMONIA IN MONKEYS.

Authors:  R L Cecil; F G Blake
Journal:  J Exp Med       Date:  1920-11-30       Impact factor: 14.307

4.  THE ACTION OF THE LETHAL DOSE OF STROPHANTHIN IN NORMAL ANIMALS AND IN ANIMALS INFECTED WITH PNEUMONIA.

Authors:  R A Jamieson
Journal:  J Exp Med       Date:  1915-11-01       Impact factor: 14.307

5.  THE CHARACTER OF THE PNEUMONIC LESIONS PRODUCED BY INTRABRONCHIAL INSUFFLATION OF VIRULENT STREPTOCOCCI.

Authors:  M Wollstein; S J Meltzer
Journal:  J Exp Med       Date:  1913-11-01       Impact factor: 14.307

6.  PNEUMONIC LESIONS MADE BY INTRABRONCHIAL INSUFFLATION OF NON-VIRULENT PNEUMOCOCCI.

Authors:  M Wollstein; S J Meltzer
Journal:  J Exp Med       Date:  1913-03-01       Impact factor: 14.307

7.  EXPERIMENTAL PULMONARY TUBERCULOSIS IN THE DOG : THE EFFECT OF LARGE AMOUNTS OF TUBERCLE BACILLI OF BOVINE TYPE INTRODUCED DIRECTLY INTO THE LUNGS BY WAY OF THE AIR PASSAGES.

Authors:  P A Lewis; C M Montgomery
Journal:  J Exp Med       Date:  1913-05-01       Impact factor: 14.307

8.  EARLY PULMONARY LESIONS IN PARTIALLY IMMUNE ALCOHOLIZED MICE FOLLOWING INHALATION OF VIRULENT PNEUMOCOCCI.

Authors:  E G Stillman; A Branch
Journal:  J Exp Med       Date:  1930-01-31       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.